Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. (Q53153760)
Jump to navigation
Jump to search
scientific article published on 31 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. |
scientific article published on 31 July 2012 |
Statements
Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. (English)
1 reference
1 reference
Tam Nguyen Dinh
1 reference
Peter Kanellakis
1 reference
Kelly To
1 reference
Peter Tipping
1 reference
Ban-Hock Toh
1 reference
Alexander Bobik
1 reference
Alex Agrotis
1 reference
31 July 2012
1 reference
1 reference
126
1 reference
10
1 reference
1256-1266
1 reference
Identifiers
1 reference